Skip to content

Drug interactions

Daunorubicin + Safinamide

Severity: Minor

Daunorubicin and Safinamide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Safinamide and its main metabolite can inhibit intestinal BCRP. Daunorubicin is not a well-established clinically relevant BCRP substrate when given intravenously, so the effect is likely to be small. The interaction is largely theoretical.

What this interaction means in plain words

Daunorubicin and Safinamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Daunorubicin belongs to Oncology; Safinamide belongs to Central Nervous System.

Evidence level: Low

Why it happens

Inhibition of intestinal BCRP by safinamide may theoretically raise exposure to BCRP substrates.

What to do

No routine change is needed. Monitor for increased anthracycline toxicity such as myelosuppression if clinically suspected.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daunorubicin and Safinamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Daunorubicin with Safinamide?

MediHelp rates the interaction as minor. Daunorubicin and Safinamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Safinamide and its main metabolite can inhibit intestinal BCRP. Daunorubicin is not a well-established clinically relevant BCRP substrate when given intravenously, so the effect is likely to be small. The interaction is largely theoretical.

How serious is the interaction between Daunorubicin and Safinamide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Monitor for increased anthracycline toxicity such as myelosuppression if clinically suspected.

What other medicines interact with Safinamide?

MediHelp also lists interactions of Safinamide with, for example, Amitriptyline, Amoxapine, Amphetamine polistirex. The full list is on the Safinamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in